Boai NKY Pharmaceuticals Ltd. | Ownership
Companies that own Boai NKY Pharmaceuticals Ltd.
China Asset Management Co., Ltd.
3,305,222
2.98%
0
0.04%
12/31/2017
Da Cheng Fund Management Co., Ltd.
526,746
0.48%
0
0.03%
12/31/2017
China Universal Asset Management Co., Ltd.
502,143
0.45%
0
0.01%
12/31/2017
E Fund Management Co., Ltd.
466,317
0.42%
0
0.01%
12/31/2017
Wanjia Asset Management Co., Ltd.
312,897
0.28%
156,449
0.05%
12/31/2017
Lion Fund Management Co., Ltd.
33,418
0.03%
0
0%
12/31/2017
Huashang Fund Management Co., Ltd.
32,883
0.03%
0
0%
12/31/2017
Soochow Asset Management Co., Ltd.
30,896
0.03%
0
0.01%
12/31/2017
AXA-SPDB Investment Managers Co., Ltd.
14,411
0.01%
0
0%
12/31/2017
Bosera Asset Management Co., Ltd.
5,350
0.01%
0
0%
12/31/2017
| Address |
No. 1888 Wenhua (East Section) Road
Jiaozuo Henan 454450
China
|
|
Employees
|
- |
| Website |
http://www.boai-nky.com |
| Updated |
07/08/2019 |
| NKY Medical Holdings Ltd. engages in the manufacture of polymers for pharmaceuticals, personal care and household industries. Its products include KoVidone K, PolyKoVidone, KoVidone I, KoVidone VA64, OraRez, PVM/MA-AN, PVM/MA-Diacid, PVM/MA-MS, WhiVidone. The company was founded on March 13, 2003 and is headquartered in Jiaozuo, China. |
